MTOR and neoplasm: Despite this, the core mechanisms suggest that nPD-L1 may exert considerable regulatory effects on other therapeutic approaches, including alterations in the tumor immunomicroenvironment (such as the interactions among mTOR signaling, autophagy, type I interferon, and immune cells) and the efficacy of immunotherapy [2, 24].